Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             257 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abstract reviewers 1999
18 1 p. 3-5
3 p.
artikel
2 A comparative study of the celsior and the University of Wisconsin solution based upon 12-hr preservation followed by transplantation in canine models 1999
18 1 p. 39-
1 p.
artikel
3 Acute native lung hyperinflation (ANLH) is not associated with poor outcome after single lung transplant (SLT) for emphysema Weill, D.
1999
18 1 p. 55-
1 p.
artikel
4 Acute rejection of cardiac allografts deficient in ICAM-1 and P-selectin 1999
18 1 p. 61-
1 p.
artikel
5 Alterations of the coronary microcirculation by soluble adhesion molecules P-selectin and ICAM-1 after cardiac transplantation in humans Wildhirt, S.M.
1999
18 1 p. 64-65
2 p.
artikel
6 Altered myocardial and endothelial expression of cyclooxygenase-2 after prolonged mechanical support in patients with severe idiopathic dilated cardiomyopathy 1999
18 1 p. 54-
1 p.
artikel
7 Analysis of risk factors for chronic lung rejection from a twelve-center, multinational database 1999
18 1 p. 59-
1 p.
artikel
8 A nation-wide list would cause major redistribution of cadaveric lungs Ely, E.W.
1999
18 1 p. 55-56
2 p.
artikel
9 A novel approach to test immunosuppressive drugs in heterotopically transplanted lung fragments in rats Ikonen, T.S.
1999
18 1 p. 73-
1 p.
artikel
10 A novel cell culture model for aerobic, hypothermic lung preservation for transplantation Cardella, J.A.
1999
18 1 p. 88-
1 p.
artikel
11 Anti-CD3: F(AB′)2-idarubicin conjugates prolong mouse cardiac allografts Mottram, P.L.
1999
18 1 p. 94-
1 p.
artikel
12 Antilymphocyte globulin (ALG) vs. placebo in immunosuppression in lung transplant 1999
18 1 p. 46-
1 p.
artikel
13 Apoptosis induced by ischemia and reperfusion in experimental lung transplantation Stammberger, U.
1999
18 1 p. 79-
1 p.
artikel
14 Apoptosis in human cardiac allografts with transplant coronary artery disease 1999
18 1 p. 90-
1 p.
artikel
15 Apoptosis in rat cardiac allograft is predominantly associated with cells of the immune response 1999
18 1 p. 40-
1 p.
artikel
16 A post mortem audit of deaths occurring beyond 30 days following heart-lung transplantation Bardsley, V.
1999
18 1 p. 41-
1 p.
artikel
17 A prospective study of haemostatic changes after implantation of the NOVACOR LVAS 1999
18 1 p. 43-
1 p.
artikel
18 Assessment of health related quality of life in pulmonary transplantation: Application of a simple generic tool Anyanwu, A.C.
1999
18 1 p. 51-
1 p.
artikel
19 Assessment of murine bone marrow transplant chimeras 1999
18 1 p. 88-
1 p.
artikel
20 Basiliximab (αIL2R Mab) induction therapy combined with subtherapeutic doses of neoral and SDZ RAD successfully prevents allograft rejection in a nonhuman primate lung transplant model Hausen, B.
1999
18 1 p. 73-
1 p.
artikel
21 8-BR-cyclic GMP given during reperfusion improves posttransplant lung edema and free radical injury Hillinger, S.
1999
18 1 p. 74-
1 p.
artikel
22 Bridge-to-transplant (BTT) experience with the Novacor left ventricular assist system (LVAS): Results of a multicenter US study 1999
18 1 p. 63-
1 p.
artikel
23 Cardiac transplant outcome between patients supported on a left ventricular assist device versus intravenous inotropic therapy 1999
18 1 p. 37-
1 p.
artikel
24 CD4 T cell mediated rejection of cardiac allografts is FAS/FASL sensitive Pietra, B.A.
1999
18 1 p. 48-
1 p.
artikel
25 Characterization of the skeletal muscle (SM) mitochondrial respiration in severe chronic heart failure (CHF) and its relations to the ventricular oxidative capacity 1999
18 1 p. 71-
1 p.
artikel
26 Clinical benefit of neoral dose monitoring with cyclosporine 2-hour peak levels compared to trough levels in stable heart transplant patients Cantarovich, M.
1999
18 1 p. 78-
1 p.
artikel
27 CMVIG favorably affects long-term outcome after heart, heart-lung and lung transplantation 1999
18 1 p. 81-
1 p.
artikel
28 Comparison of euro collins®- and low potassium dextran (perfadex®) -solution in clinical lung preservation Mu¨ller, C.
1999
18 1 p. 40-
1 p.
artikel
29 Comparison of long-term effects between tacrolimus and cyclosporine based immunosuppression after HTx 1999
18 1 p. 78-
1 p.
artikel
30 Competitive RT-PCR for granzyme-B, IL-15 and rantes for molecular diagnosis of lung allograft rejection Zeevi, A.
1999
18 1 p. 81-82
2 p.
artikel
31 Comprehensive concept to support right ventricular function following left ventricular assist device implantation Wagner, F.
1999
18 1 p. 89-
1 p.
artikel
32 Continuing medical education information 1999
18 1 p. 6-
1 p.
artikel
33 Cooperative procurement for lung transplantation improves organ utilization without increasing complications 1999
18 1 p. 86-87
2 p.
artikel
34 Coronary arteries of human cardiac allograts with transplant coronary artery disease contain oligoclonal populations of T lymphocytes 1999
18 1 p. 60-
1 p.
artikel
35 Coronary vasomotor response to the selective B1 kinin receptor agonist des-arg9-bradykinin in transplant patients 1999
18 1 p. 64-
1 p.
artikel
36 Criteria for selecting type of bridge to heart transplantation: The univertity of arizona experience 1999
18 1 p. 89-
1 p.
artikel
37 Cyclic AMP stimulation protects a porcine pulmonary xenograft from hyperacute rejection 1999
18 1 p. 65-
1 p.
artikel
38 Cytokine transcripts in coronary arteries and coronary artery-derived T-cell lines from patients with chronic rejection 1999
18 1 p. 41-
1 p.
artikel
39 Cytomegalovirus immune globulin (CMVIG) in combination with gancyclovir provides cost-effective prophylaxis of CMV after lung transplantation (LTX) 1999
18 1 p. 81-
1 p.
artikel
40 Death after heart transplantation in children: Who dies when and why 1999
18 1 p. 69-70
2 p.
artikel
41 Decreased survival associated with size mis-matching in lung transplantation 1999
18 1 p. 60-
1 p.
artikel
42 Development and spectrum of PTLD in 691 cardiac transplant (Htx) recipients receiving induction therapy Mallinger, R.
1999
18 1 p. 77-
1 p.
artikel
43 Development of a simple risk model for predciting survival after adult orthotopic heart transplantation Anyanwu, A.C.
1999
18 1 p. 37-38
2 p.
artikel
44 Development of post lung transplant obliterative bronchiolitis is characterized by increased exhaled nitric oxide, upregulation of iNOS and downregulation of cNOS 1999
18 1 p. 51-
1 p.
artikel
45 Diagnostic value of structured interviews in assessing noncompliance with immunosuppressive therapy in heart transplant recipients De Geest, S.
1999
18 1 p. 91-
1 p.
artikel
46 Differences in rejection of rat heart transplants are determined by passenger leukocyte genotype 1999
18 1 p. 68-
1 p.
artikel
47 Differential effects of cellular cardiomyoplasty on systolic and diastolic performance in cryoinjured rabbit myocardium 1999
18 1 p. 43-
1 p.
artikel
48 Differential time scale of fluid and solute permeability following hypothermic lung preservation Rooney, S.J.
1999
18 1 p. 73-
1 p.
artikel
49 Differentiation of human cytomegalovirus (CMV) glycoprotein B and glycoprotein H types by restriction fragment length polymorphism — association of glycoprotein types with CMV disease in heart, heart-lung and lung transplant recipients 1999
18 1 p. 82-
1 p.
artikel
50 Does cardiac transplantation affect gynecologic and reproductive outcomes? 1999
18 1 p. 58-59
2 p.
artikel
51 Does initial photopheresis have an impact on the development of graft atherosclerosis after cardiac transplantation — a 6-year follow-up Kur, F.
1999
18 1 p. 93-
1 p.
artikel
52 Does LVAD bridging-to-transplantation increase graft vasculopathy? Kaplon, R.J.
1999
18 1 p. 63-
1 p.
artikel
53 Does time to harvest determine outcome in heart transplantation with older allografts? 1999
18 1 p. 39-
1 p.
artikel
54 Domino heart transplantation: 10 years experience Ongcharit, P.
1999
18 1 p. 37-
1 p.
artikel
55 Donor and recipient contributions of ICA-1 and P-selectin in parenchymal rejection and graft arteriosclerosis: Insights from double knockout mice 1999
18 1 p. 61-
1 p.
artikel
56 Donor pre-treatment with inhaled nitric oxide attenuates acute lung injury following single lung transplantation Sudarshan, C.D.
1999
18 1 p. 78-
1 p.
artikel
57 Donor-specific high avidity cytotoxic T-lymphocytes induced by implantation of cryopreserved human cardiac valves 1999
18 1 p. 53-
1 p.
artikel
58 Donor specific spleen cells mediate allograft survival by a different mechanism than bone marrow 1999
18 1 p. 69-
1 p.
artikel
59 Dose and time relationship of cyclosporine on chronic graft vascular disease after transplantation in a rat cardiac isograft model Teranishi, K.
1999
18 1 p. 73-
1 p.
artikel
60 Dynamic aortomyoplasty with latissimus dorsi. Clinical follow-up 1999
18 1 p. 42-43
2 p.
artikel
61 Early graft dysfunction in pediatric lung transplant recipients 1999
18 1 p. 82-83
2 p.
artikel
62 Early mediators of lung ischaemia-reperfusion injury Onwu, N.
1999
18 1 p. 74-
1 p.
artikel
63 Editorial Board 1999
18 1 p. A7-
1 p.
artikel
64 Education and the transplanted child 1999
18 1 p. 57-
1 p.
artikel
65 Effective treatment of lymphoproliferative disease following lung transplantation using a monoclonal anti-CD20 B-cell antibody 1999
18 1 p. 84-85
2 p.
artikel
66 Effect of donor age on young and older lung transplant recipients 1999
18 1 p. 85-
1 p.
artikel
67 Effect of histocompatibility, sensitization and other risk factors on the outcome of 14,535 cardiac transplants (TNX) reported to the unos scientific registry 1999
18 1 p. 38-39
2 p.
artikel
68 Effect of soluble complement receptor type 1 (sCR1) on experimental obliterative bronchiolitis (OB) Kallio, E.A.
1999
18 1 p. 52-53
2 p.
artikel
69 Effects of celsior preservation solution on myocardial performance and coronary vasomotor function after 2 h of global ischemia in isolated rat hearts Wildhirt, S.M.
1999
18 1 p. 40-
1 p.
artikel
70 Effects of endothelin A and B receptor antagonists on myocardial and endothelial injury during reperfusion by after heart transplantation 1999
18 1 p. 54-
1 p.
artikel
71 Effects of MHC class II antigens on the development of cardiac allograft vasculopathy in miniature swine Mawulawde, K.
1999
18 1 p. 53-
1 p.
artikel
72 Effects of oral ganciclovir on the prevention of cytomegalovirus infection in lung transplant recipients 1999
18 1 p. 85-
1 p.
artikel
73 Effects of throm☐ane synthase inhibition on hyperacute rejection of lungs (HALR) transgenic for human decay accelerating factor (hDAF) 1999
18 1 p. 54-
1 p.
artikel
74 Efficacy and safety of sildenafil citrate (VIAGRA) in male heart transplant patients 1999
18 1 p. 58-
1 p.
artikel
75 Efficacy of donor specific bone marrow in reducing frequency of rejection following heart transplantation McGurl, P.A.
1999
18 1 p. 93-
1 p.
artikel
76 Epithelial re-growth prevents luminal occlusion in orthotopic tracheal allografts despite acute rejection and proliferation of α-actin positive cells Ikonen, T.S.
1999
18 1 p. 60-
1 p.
artikel
77 Evaluation of a mentorship programme for heart transplant patients Pennington, J.J.
1999
18 1 p. 91-
1 p.
artikel
78 Evaluation of circulating epstein-barr virus (EBV) viral load in pediatric thoracic recipients: Implications for diagnosis of posttransplant lymphoproliferative disorders (PTLD) 1999
18 1 p. 83-
1 p.
artikel
79 Evaluation of regional wall motion abnormalities and ventricular function in pediatric heart transplant patients using dobutamine stress echocardiography 1999
18 1 p. 84-
1 p.
artikel
80 Factors affecting outcome in patients “Too well” for heart transplantation at initial assessment 1999
18 1 p. 46-
1 p.
artikel
81 Failure to wean from parenteral inotropes: A strong predictor for early mortality among patients with end stage heart disease 1999
18 1 p. 47-48
2 p.
artikel
82 Famciclovir treatment of chronic hepatitis B in heart transplant recipients 1999
18 1 p. 81-
1 p.
artikel
83 Feasibility of a pumpless extracorporeal respiratory assist device 1999
18 1 p. 41-42
2 p.
artikel
84 Five-year follow-up of a randomized trial of pravastatin in heart transplant patients 1999
18 1 p. 71-
1 p.
artikel
85 Five years of living lobar donation for bilateral lung transplantation: Long term results in 137 donors 1999
18 1 p. 54-
1 p.
artikel
86 Five years results of a prospective randomized study comparing a rabbit ATG versus a monoclonal anti-CD25 antibody in de novo cardiac transplant recipients 1999
18 1 p. 94-
1 p.
artikel
87 Functional responses of anti-CD25 blocked T-cells during cardiac rejection Baan, C.C.
1999
18 1 p. 69-
1 p.
artikel
88 Ganciclovir and rat cytomegalovirus (RCMV) antisera prophylaxis prevent RCMV infection-enhanced experimental obliterative bronchiolitis (OB) in the rat Tikkanen, J.M.
1999
18 1 p. 62-
1 p.
artikel
89 Gastroesophageal reflux is an important cause of allograft dysfunction in lung transplant recipients 1999
18 1 p. 51-
1 p.
artikel
90 Gender mismatch is not associated with reduced survival after heart transplantation 1999
18 1 p. 44-
1 p.
artikel
91 Gene therapy with soluble FAS decreases AGA in a rat aortic allograft model Wang, Tao
1999
18 1 p. 48-49
2 p.
artikel
92 Genetic polymorphism of transforming growth factor-β (codon 25) and development of cardiac allograft vascular disease Pethig, K.
1999
18 1 p. 52-
1 p.
artikel
93 Gene transfection of donor lungs prior to organ procurement increases transgene levels at reperfusion and following transplantation Cassivi, S.D.
1999
18 1 p. 88-89
2 p.
artikel
94 Heart and lung transplantation from poisoned braindead donors: A 10-year United Kingdom experience Tsui, S.S.L.
1999
18 1 p. 78-79
2 p.
artikel
95 Hemodynamic compromising rejection is associated with increased incidence of transplant coronary artery disease in cardiac transplant recipients 1999
18 1 p. 50-
1 p.
artikel
96 Hemodynamic guided inotropic tailoring does not appear to impact long term survival among patients requiring chronic home inotropic therapy 1999
18 1 p. 43-
1 p.
artikel
97 Hemoglobin A1C predicts of transplant coronary artery disease incidence and severity 1999
18 1 p. 50-
1 p.
artikel
98 Hepatitis C virus (HCV) positive donor hearts: Impact on morbidity and mortality 1999
18 1 p. 39-
1 p.
artikel
99 Heterogeneity and reversal of bronchiolitis obliterans syndrome 1999
18 1 p. 59-60
2 p.
artikel
100 High dose brachytherapy to prevent recurrent benign hyperplasia in lung transplant bronchi; theoretical and clinical applications Sonnett, J.R.
1999
18 1 p. 84-
1 p.
artikel
101 High frequency of intragraft IFN-γ producing CD8+ T cells is predictive of lung allograft rejection 1999
18 1 p. 82-
1 p.
artikel
102 Histopathology of resected myocardium is correlated with survival after partial left ventriculectomy - a clue to indication for PLV versus transplantation Kawaguchi, A.T.
1999
18 1 p. 67-
1 p.
artikel
103 HLA class II matching: Significant impact on long term outcome of lung transplantation 1999
18 1 p. 85-
1 p.
artikel
104 Human lung preservation can be extended beyond eight hours using UW solution 1999
18 1 p. 87-
1 p.
artikel
105 Hypersensitivity eosinophilia: A unique cause of cardiac decompensation in inotropic dependent heart failure? 1999
18 1 p. 43-
1 p.
artikel
106 Hypertension during support with ventricular assist devices: Incidence, risk factors and management 1999
18 1 p. 58-
1 p.
artikel
107 IGM to IGG anti-HLA class II antibody switching in cardiac transplant recipients reflects T cell responses to donor HLA-DR peptides and is associated with increased risk of cellular rejection and coronary artery disease 1999
18 1 p. 80-
1 p.
artikel
108 IL-6 and IFN-γ expression parallels recovery of the epithelium in a heterotopic rat model of allograft rejection Wan, B.
1999
18 1 p. 90-
1 p.
artikel
109 Immunoglobulin adsorption as effective treatment of severe dilated cardiomyopathy Mu¨ller, J.
1999
18 1 p. 70-71
2 p.
artikel
110 Immunologic assessment of risk for rejections after heart transplantation 1999
18 1 p. 80-
1 p.
artikel
111 Immunomodulatory effects of donor bone marrow infusion in heart or lung transplantation: Five year experience 1999
18 1 p. 72-
1 p.
artikel
112 Impact of antibodies to HLA class I molecules on the development of BOS 1999
18 1 p. 51-
1 p.
artikel
113 Impact of donor brain death on tempo and intensity of acute rejection of rat cardiac allografts Wilhelm, M.J.
1999
18 1 p. 68-
1 p.
artikel
114 Impact of morphology and ventilatory mechanics upon early functional outcome after lung volume reduction surgery Wisser, W.
1999
18 1 p. 42-
1 p.
artikel
115 Impact of patient noncompliance on survival in cardiac transplant recipients 1999
18 1 p. 38-
1 p.
artikel
116 Implantable left ventricular assist devices can successfully bridge pediatric patients to transplant 1999
18 1 p. 89-
1 p.
artikel
117 Improved prevention of graft arteriosclerosis with thymoglobuline induction therapy in patients after cardiac transplantation 1999
18 1 p. 93-94
2 p.
artikel
118 Improved results for retransplantation in acute and late pulmonary graft failure 1999
18 1 p. 56-
1 p.
artikel
119 Increased intragraft expression of TGF-β mRNA in patients with graft vascular disease after clinical heart transplantation 1999
18 1 p. 52-
1 p.
artikel
120 Increased or de novo expression of ICAM-1, VCAM-1 and E-selectin on cytomegalovirus-infected endothelial and vascular smooth muscle cells is induced by il-1β release 1999
18 1 p. 61-
1 p.
artikel
121 Index to authors of abstracts 1999
18 1 p. 95-105
11 p.
artikel
122 Indirect allorecognition of HLA class II allopeptides in lung allograft recipients Reznik, S.I.
1999
18 1 p. 68-
1 p.
artikel
123 Induction of cardiac allograft endothelial dysfunction by cytokines in humans 1999
18 1 p. 64-
1 p.
artikel
124 Inflammatory cytokines and hepatic sinusoid endothelial dysfunction play a role in hyperbilirubinemia in patients following implantation of an LVAS 1999
18 1 p. 57-
1 p.
artikel
125 Influence of HLA matching on survival and development of obliterative bronchiolitis (OB) after lung transplantation 1999
18 1 p. 50-51
2 p.
artikel
126 Influence of ischemic time on hyperacute xenograft rejection in a working pig heart model with immunoadsorption 1999
18 1 p. 59-
1 p.
artikel
127 Inhaled nitric oxide in early severe allograft lung dysfunction Planas, A.
1999
18 1 p. 55-
1 p.
artikel
128 Inhibition of hyperacute pig-to-human xenograft rejection by modulating the fluid-phase complement activation 1999
18 1 p. 66-
1 p.
artikel
129 Inhibition of throm☐ane A2 and platelet adhesion with salicylic acid effectively ameliorates reperfusion injury following acute double lung transplantation in the rat Hausen, B.
1999
18 1 p. 79-80
2 p.
artikel
130 Inter-hospital transfer of patients receiving advanced mechanical circulatory support 1999
18 1 p. 90-
1 p.
artikel
131 International Society for Heart and Lung Transplantation 1999
18 1 p. 1-
1 p.
artikel
132 International survey of routine surveillance biopsy practices in adult heart transplantation Aaronson, K.D.
1999
18 1 p. 80-
1 p.
artikel
133 Intraoperative liposome-mediated gene transfection of nitric oxide synthase (ecNOS) reduces ischemia-reperfusion injury in transplanted hearts 1999
18 1 p. 37-
1 p.
artikel
134 Intravascular ultrasound has prognostic impact after heart transplantation: A multivariable analysis in a large patient cohort 1999
18 1 p. 50-
1 p.
artikel
135 Intravenous (IV) inotrope and vasodilator therapy in a critical care setting utilizing a heart failure specialty team care approach (HFSTC) with “hemodynamic goal” protocols vs a general cardiology care approach (GCC) 1999
18 1 p. 75-
1 p.
artikel
136 In-vivo measurement of oxygen free radical production correlates with pulmonary reperfusion injury 1999
18 1 p. 74-
1 p.
artikel
137 Is it safe to utilize hearts from donors with positive blood cultures? 1999
18 1 p. 79-
1 p.
artikel
138 Is the use of donor hearts with left ventricular hypertrophy acceptable? 1999
18 1 p. 87-
1 p.
artikel
139 Is the use of left ventricular assist device as a bridge to heart transplantation a risk factor for development of transplant coronary artery disease? 1999
18 1 p. 63-
1 p.
artikel
140 IVIG postpones alloimmunization in LVAD and artificial heart recipients 1999
18 1 p. 57-
1 p.
artikel
141 Late functional outcome after transplantation (Tx) versus norwood 3 stage palliation (Nw) for infants with hypoplastic left heart syndrome (HLHS) 1999
18 1 p. 70-
1 p.
artikel
142 Late rejection greater than 1 year after pediatric heart transplantation: An ominous finding 1999
18 1 p. 69-
1 p.
artikel
143 Left ventricular diastolic function after bicaval and standard cardiac transplantation 1999
18 1 p. 44-45
2 p.
artikel
144 Left ventricular reconstruction using the DOR procedure for ischemic aneurysm or akinetic dilatation Marullo, A.G.M.
1999
18 1 p. 42-
1 p.
artikel
145 Long-term follow-up of thoratec ventricular assist device bridge-to-recovery patients after resolution of non-ischemic heart failure 1999
18 1 p. 62-63
2 p.
artikel
146 Long term home discharge support with novacor LVAS 1999
18 1 p. 67-68
2 p.
artikel
147 Long term physical training in cardiac transplant candidates: Is it feasible? 1999
18 1 p. 75-76
2 p.
artikel
148 Loss of airway goblet cells is associated with respiratory epithelial injury in a rat model of allograft rejection Wan, B.
1999
18 1 p. 90-
1 p.
artikel
149 Low cardiac neuronal function and predicted value of maximum oxygen consumption predict for high risk of cardiac events in cardiomyopathy 1999
18 1 p. 47-
1 p.
artikel
150 Low producers of TGF beta are protected from cardiac transplant vasculopathy 1999
18 1 p. 52-
1 p.
artikel
151 LPD solution in clinical lung transplantation Stru¨ber, M.
1999
18 1 p. 87-
1 p.
artikel
152 Maintaining or improving nutritional parameters for patients awaiting lung transplantation Endres, N.L.
1999
18 1 p. 91-
1 p.
artikel
153 Maximizing thoracic organ transplant (TOTx) opportunities- the importance of efficient co-ordination 1999
18 1 p. 86-
1 p.
artikel
154 Mechanical unloading restores beta-adrenergic responsiveness in the failing human heart 1999
18 1 p. 63-
1 p.
artikel
155 Mechanisms of brain death associated myocardial dysfunction 1999
18 1 p. 87-
1 p.
artikel
156 Mechanisms of coronary artery remodeling in heart transplant recipients. A serial study with intravascular ultrasound and three-dimensional vessel reconstruction 1999
18 1 p. 65-
1 p.
artikel
157 Medium term results of children with two hearts 1999
18 1 p. 84-
1 p.
artikel
158 Meeting information 1999
18 1 p. 6-35
30 p.
artikel
159 Metallothionein is involved in reverse remodelling after prolonged left ventricular assist device support 1999
18 1 p. 57-
1 p.
artikel
160 Modulation of pulmonary Na+ pump gene expression during cold storage and reperfuson 1999
18 1 p. 74-
1 p.
artikel
161 MPA-dose adjustment based on trough levels- high and low dose pharmacokinetics in heart transplanted patients Schmidt, D.
1999
18 1 p. 46-
1 p.
artikel
162 Multicenter, double-blind, randomized study of neoral vs sandimmune in heart transplantation: One year results 1999
18 1 p. 93-
1 p.
artikel
163 Mycophenolate mofetil for secondary prevention of allograft vasculopathy following heart transplantation: A prospective; randomized; intravascualr ultrasound controlled trial Pethig, K.
1999
18 1 p. 77-78
2 p.
artikel
164 Mycophenolate mofetil in paediatric heart transplant recipients: A single center experience 1999
18 1 p. 83-84
2 p.
artikel
165 Mycophenolic acid concentrations are associated with cardiac allograft rejection 1999
18 1 p. 46-
1 p.
artikel
166 Myocardial HLA and ICAM-1 staining pattern in biopsies from transplanted hearts. Three years follow-up 1999
18 1 p. 40-
1 p.
artikel
167 Noncompliance causing late acute rejection in pediatric heart transplantation 1999
18 1 p. 70-
1 p.
artikel
168 Noninvasive cardiac graft monitoring: The graz experience Grasser, B.
1999
18 1 p. 80-
1 p.
artikel
169 Noninvasive. Cost-effective detection of cardiac allograft vasculopathy by electron beam computed tomography (EBCT) 1999
18 1 p. 49-
1 p.
artikel
170 Optimal timing of lung transplantation in cystic fibrosis patients 1999
18 1 p. 86-
1 p.
artikel
171 Outcome of infants listed for lung or heart/lung transplantation 1999
18 1 p. 83-
1 p.
artikel
172 Outcome of listing for cardiac transplantation for failed fontan: A multi-institutional study 1999
18 1 p. 69-
1 p.
artikel
173 Outcomes with hepatitis C following cardiac transplantation — a multi-institutional study 1999
18 1 p. 81-
1 p.
artikel
174 Outpatient inotropic therapy in refractory heart failure Oliva, Fabrizio
1999
18 1 p. 75-
1 p.
artikel
175 Patient outcome and costs following an acute heart failure (HF) management program in an emergency department (ED) observation unit (OU) 1999
18 1 p. 92-
1 p.
artikel
176 Pediatric cardiac retransplantation: Experience at a single institution Dearani, J.A.
1999
18 1 p. 70-
1 p.
artikel
177 Pediatric heart transplant school re-entry Rodgers, S
1999
18 1 p. 58-
1 p.
artikel
178 Post-transplant lymphoproliferative disease (PTLD) following lung transplantation in Canadian transplant centers 1999
18 1 p. 85-
1 p.
artikel
179 p21 overexpression inhibits cell proliferation and enhances cyclosporine's antiproliferative effects: A novel strategy for immunosuppression 1999
18 1 p. 49-
1 p.
artikel
180 Predictors of survival to transplant in cystic fibrosis: Impact of international listing guidelines 1999
18 1 p. 55-
1 p.
artikel
181 Pressure mediated delivery of decoy NF-κB binding oligodeoxynucleotides decreases reperfusion injury in rodent cardiac allografts 1999
18 1 p. 48-
1 p.
artikel
182 Pretransplant panel reactive antibodies are associated with increased risk of transplant coronary artery disease (TCAD) in cardiac transplant recipients 1999
18 1 p. 76-
1 p.
artikel
183 Prevention of chronic rejection by nonselective endothelin receptor antagonist Sihvola, R.K.
1999
18 1 p. 61-62
2 p.
artikel
184 Prevention of endothelial cell activation in hamster-to-rat cardiac xenografts by gene transfection of BCL-2 1999
18 1 p. 66-
1 p.
artikel
185 Profile of soluble coagulant and inflammatory markers during long-term left ventricular assist device support 1999
18 1 p. 56-57
2 p.
artikel
186 Prognostic value of circulating levels of interleukin-6 in patients with congestive heart failure 1999
18 1 p. 91-92
2 p.
artikel
187 Prognostic value of low versus high dosage of angiotensin converting enzyme inhibitors in patients awaiting heart transplantation 1999
18 1 p. 75-
1 p.
artikel
188 Prognostic value of the relative lymphocyte concentration and white blood cell count in heart failure 1999
18 1 p. 47-
1 p.
artikel
189 Program committee 1999
18 1 p. 2-
1 p.
artikel
190 Prophylactic and preemptive strategies for control of legionnaires' disease in heart transplant recipients. A single center 10-years survey in a high-risk environment 1999
18 1 p. 77-
1 p.
artikel
191 Prospective randomized two-center trial comparing cyclosporine A (CSA) vs. tacrolimus (TAC), in combination with mycophenolate mofetil (MMF) and steroids after lung transplantation (LTX) 1999
18 1 p. 45-46
2 p.
artikel
192 Prostacyclin- and throm☐ane-synthases in transplanted human hearts. Relation to coronary endothelial function 1999
18 1 p. 64-
1 p.
artikel
193 Psychological evaluation as a prognostic factor among patients candidates for cardiac transplantation Moscoloni, S.E.
1999
18 1 p. 58-
1 p.
artikel
194 Public and professional attitudes toward xenotransplantion and other options to increase organ availability 1999
18 1 p. 92-
1 p.
artikel
195 Pulmonary volume increases with linear growth in pediatric living donor lobar lung transplant recipients 1999
18 1 p. 86-
1 p.
artikel
196 RacCA gene transfer supresses the development of aortic allograft arteriosclersosis in the rat 1999
18 1 p. 48-
1 p.
artikel
197 Randomised trial of blood eosinophil count (EOS) monitoring to guide steroid dose adjustment in the control of heart allograft rejection 1999
18 1 p. 93-
1 p.
artikel
198 Randomised trial of cardiomyoplasty against optimal medical therapy in class III heart failure 1999
18 1 p. 67-
1 p.
artikel
199 Recipient weight as an independent risk factor in heart transplantation Mullen, G.M.
1999
18 1 p. 92-
1 p.
artikel
200 Reductions in type 1 fibre proportions and oxidative enzyme activity in skeletal muscle exist pre & post lung transplantation Morton, J.M.
1999
18 1 p. 52-
1 p.
artikel
201 Refining the criteria for heart transplant listing and status: A multi-institutional risk factor analysis for rehospitalization following listing 1999
18 1 p. 47-
1 p.
artikel
202 Regulatory roles of chemokines in delayed cardiac xenograft rejection 1999
18 1 p. 59-
1 p.
artikel
203 Resting left ventricular size predicts improved native cardiac output during exercise and the ability to exercise with the device weaned in patients with the TCI heartmate left ventricular assist device 1999
18 1 p. 44-
1 p.
artikel
204 Resting myocardial blood flow and metabolism predicts improved native left ventricular output and the ability to exercise with weaning in patients with the TCI heartmate left ventricular assist device Maybaum, S.
1999
18 1 p. 62-
1 p.
artikel
205 Results of expandable metal stent placement in lung transplant recipients 1999
18 1 p. 60-
1 p.
artikel
206 Results of lung transplantation following lung volume reduction surgery Wisser, W.
1999
18 1 p. 67-
1 p.
artikel
207 Revascularisation for post-ischaemic heart failure: How myocardial viability affects survival Pagano, D.
1999
18 1 p. 67-
1 p.
artikel
208 Reversal of the heart failure phenotype by mechanical unloading 1999
18 1 p. 89-90
2 p.
artikel
209 Risk factor analysis for inappropriate growth after pediatric heart transplantation(HTX) 1999
18 1 p. 91-
1 p.
artikel
210 175 Risk factor analysis for skin cancer in heart transplant (HT) recipients Belloni, A.
1999
18 1 p. 77-
1 p.
artikel
211 Role of neural and humoral factors in cardiac dysfunction in the potential organ donor 1999
18 1 p. 39-
1 p.
artikel
212 Selective adenosine-a 2A activation reduces lung reperfusion injury following transplantation 1999
18 1 p. 72-
1 p.
artikel
213 Sequential evaluation of big endothelin plasma concentration in patients with advanced heart failure: Effects of therapy 1999
18 1 p. 47-
1 p.
artikel
214 Should advanced recipient age be contraindicated in cardiac transplantation? Continued analysis of a single center experience 1999
18 1 p. 45-
1 p.
artikel
215 Sirolimus (Rapamycin) blood levels correlate with prevention of graft vascular disease (GVD) in monkey aortic transplants as monitored by intravascular ultrasound 1999
18 1 p. 72-
1 p.
artikel
216 Soluble rat class I MHC proteins induce prolonged survival of rat cardiac allografts 1999
18 1 p. 68-
1 p.
artikel
217 Stat4-mediated TH1 responses promote the development ofgraft arteriosclerosis 1999
18 1 p. 71-
1 p.
artikel
218 Successful cardiac transplantation of pre-sensitized children without a prospective crossmatch: Preliminary results 1999
18 1 p. 83-
1 p.
artikel
219 Successful lung transplantation with the use of marginal donors 1999
18 1 p. 79-
1 p.
artikel
220 Survival outcomes of patients with giant cell myocarditis bridged by ventricular assist devices 1999
18 1 p. 43-44
2 p.
artikel
221 Synergistic effect of endothelin- and PAF antagonists on posttransplant lung ischemia/reperfusion injury Stammberger, U.
1999
18 1 p. 74-75
2 p.
artikel
222 T cell activation in left ventricular assist device (LVAD) recipients occurs via a CD95-dependent pathway, and results in loss of th1 cells and high levels of circulating IL-10 1999
18 1 p. 56-
1 p.
artikel
223 T cell apoptosis and defects in cellular immunity induced by exposure to biomaterials: Implications for left ventricular assist device (LVAD) implantation Ankersmit, J
1999
18 1 p. 56-
1 p.
artikel
224 Temporal pattern of T lymphocyte and macrophage infiltration in a nonimmunosuppressed model of CAV 1999
18 1 p. 40-41
2 p.
artikel
225 Temporary ECMO support following lung and heart-lung transplantation 1999
18 1 p. 55-
1 p.
artikel
226 TGF beta polymorphism does not influence the rise in creatinine following cardiac transplantation 1999
18 1 p. 77-
1 p.
artikel
227 The actions of cyclosporine-A on apoptosis and p53 expression in human vascular smooth muscle cells 1999
18 1 p. 61-
1 p.
artikel
228 The effect of inhaled steroids on exhaled nitric oxide in lung transplant recipients with lymphocytic bronchitis 1999
18 1 p. 45-
1 p.
artikel
229 The effect of intra-pulmonary CXC-chemokines in the donor lung on early graft function after lung transplantation Fisher, A.J.
1999
18 1 p. 88-
1 p.
artikel
230 The effect of pre lung transplant clinical status on post transplant outcome for children with cystic fibrosis: A ten year experience 1999
18 1 p. 83-
1 p.
artikel
231 The effects of inhaled nitric oxide, gabexate mesilate (FOY), and retrograde perfusion in the lung grafts from non-heart-beating minipig donors 1999
18 1 p. 62-
1 p.
artikel
232 The immunomodulatory role of simvastatin and pravastatin on cardiac allograft rejection: A prospective randomized trial 1999
18 1 p. 76-
1 p.
artikel
233 The impact of early myocardial endothelin expression on functional and morphological coronary alterations during follow-up in cardiac transplant recipients 1999
18 1 p. 64-
1 p.
artikel
234 The impact of explosive brain death on the genesis of cardiac allograft vasculopathy: An intravascular ultrasound study 1999
18 1 p. 49-
1 p.
artikel
235 The impact of ganciclovir-resistant cytomegalovirus infection in lung transplantation 1999
18 1 p. 82-
1 p.
artikel
236 The impact of HLA sensitization and donor cause of death in heart transplantation 1999
18 1 p. 38-
1 p.
artikel
237 The international lung transplant database: Demographics and outcomes in 826 lung transplant recipients 1999
18 1 p. 86-
1 p.
artikel
238 Therapeutic monitoring of mycophenolic acid (MPA): Assays of immune function in peripheral blood predict efficacy for inhibition of histologic graft rejection Gummert, J.F.
1999
18 1 p. 53-54
2 p.
artikel
239 The regulatory role of IL-10 in experimental obliterative bronchiolitis (OB) Mulligan, M.S.
1999
18 1 p. 88-
1 p.
artikel
240 The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants Lau, Christine L.
1999
18 1 p. 65-66
2 p.
artikel
241 The role of flow cytometry detected IgG and IgM anti-donor antibodies in cardial allograft recipients 1999
18 1 p. 38-
1 p.
artikel
242 The role of lipids and fibrinogen in coronary vasomotor dysfunction after cardiac transplantation 1999
18 1 p. 50-
1 p.
artikel
243 The significance of bronchial associated lymphoid tissue in human lung transplantation: Is there an association with acute and chronic rejection? 1999
18 1 p. 41-
1 p.
artikel
244 Three year results of the double-blind randomized multicenter trial of mycophenolate mofetil in heart transplant patients 1999
18 1 p. 53-
1 p.
artikel
245 Time course of reverse left ventricular remodeling in response to carvedilol in heart failure 1999
18 1 p. 76-
1 p.
artikel
246 Transforming growth factor-beta (TGF-B) and allograft vasculopathy following heart transplantation Aziz, T
1999
18 1 p. 37-
1 p.
artikel
247 Transmyocardial laser revascularisation in class IV angina — A randomised trial 1999
18 1 p. 42-
1 p.
artikel
248 Transmyocardial laser revascularization (TMR) in ischemic cardiomyopathy Grauhan, O.
1999
18 1 p. 66-
1 p.
artikel
249 Transplantation of “thymoheart” allografts in miniature swine Menard, M.T.
1999
18 1 p. 71-
1 p.
artikel
250 Treatment differences and clinical outcomes of advanced heart failure (HF) patients with a critical care admission using specialist team protocols vs. general cardiology care 1999
18 1 p. 76-
1 p.
artikel
251 Use of daclizumab decreases the frequency of early allograft rejection in de-novo heart transplant recipients 1999
18 1 p. 45-
1 p.
artikel
252 Use of inhaled nitric oxide in cardiac transplantation 1999
18 1 p. 44-
1 p.
artikel
253 Use of sequence specific oligodeoxynucleotides to inhibit myointimal proliferation associated with graft coronary artery disease 1999
18 1 p. 49-
1 p.
artikel
254 Von willebrand deficient swine lungs transplanted into baboons Lau, Christine L.
1999
18 1 p. 65-
1 p.
artikel
255 VX-497 inhibits IMPDH and is the first rationally synthesized immunosuppressant to prolong allograft survival Gummert, J.F.
1999
18 1 p. 72-
1 p.
artikel
256 What are the attitudes of potential heart and heart-lung patients to xenotransplantation? 1999
18 1 p. 92-
1 p.
artikel
257 Xenogeneic antibodies are not necessary for chronic rejection of vascularised xenografts Briffa, Norman P
1999
18 1 p. 66-
1 p.
artikel
                             257 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland